Question 1

What is the catalog number for Xestospongin C, Inhibits IP3-mediated Ca2+ release?

Accepted Answer

The catalog number for Xestospongin C, Inhibits IP3-mediated Ca2+ release is TBI1207-10UG.

Question 2

What sizes are available for Xestospongin C, Inhibits IP3-mediated Ca2+ release?

Accepted Answer

Xestospongin C, Inhibits IP3-mediated Ca2+ release is available in the following size(s): 10 µg.

Question 3

Is Xestospongin C, Inhibits IP3-mediated Ca2+ release in stock?

Accepted Answer

Xestospongin C, Inhibits IP3-mediated Ca2+ release is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Xestospongin C, Inhibits IP3-mediated Ca2+ release

Product Specifications

Bioactivity

Shipping Conditions

Frequently Asked Questions

Explore Other Products

CD11c (HC1/1), CF647 conjugate, 0.1mg/mL

Cytokeratin, HMW (AE-3), CF568 conjugate, 0.1mg/mL

CD43 (84-3C1), CF647 conjugate, 0.1mg/mL

Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF640R conjugate, 0.1mg/mL

CD46 (122.2), CF405S conjugate, 0.1mg/mL

Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/782), CF640R conjugate, 0.1mg/mL